NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Peptidus Biotech

Peptidus Biotech

Private
BrasíliaHealthcare & Life Scienceshttps://peptidus.com/

Last Round

Pre Seed

Dec 1, 2024

Company Overview

Peptidus Biotech is a biotechnology company that develops novel bioactive peptides for animal health therapies using a proprietary AI-powered platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

peptide drug discoveryAI drug discoveryanimal healthAI biotechplatform biotechpeptide therapeuticsveterinary medicinebiotech licensingdrug discovery platformin-silico drug designgenerative biologycompanion animal healthlivestock healthmastitis treatmentatopic dermatitis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peptidus Biotech Comparables

Compare Peptidus Biotech with similar companies based on industry and business-model similarity.

Peptidus Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Peptidus Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 1, 2024

Key People

Founding team and executive leadership

Bernardo Petriz

Co-Founder & CEO

Founding Team

Lucas Delgado

COO

Executive Team

Peptidus Biotech Investors

Notable investors and investment history

Peptidus Biotech investors
InvestorRounds
Conselho Nacional de Desenvolvimento Científico e TecnológicoPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 87% MoM.

  • Dec 1, 2024

    Raised Pre Seed round with investors including Emerge Brasil.

Peptidus Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Peptidus Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Peptidus Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrasília
Employee Range9
Year Founded2019
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.